ICMH
COEPW

Integrity Capital Management (HK)’s Coeptis Therapeutics Warrants COEPW Stock Holding History

Integrity Capital Management (HK)’s Portfolio COEPW Stock Details COEPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-54,649
Closed -$4K – 30
2022
Q1 		$4K Hold
54,649
– – 0.02% 150
2021
Q4 		$18K Buy
+54,649
New +$18.2K 0.06% 299

Other funds holding COEPW

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
BCM
Basso Capital Management Stamford, Connecticut $163M AUM 21.95% 1-Year Est. Return
KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Integrity Capital Management (HK)'s COEPW Position: Q2 2022 in Review

Integrity Capital Management (HK) sold out of Coeptis Therapeutics Warrants (COEPW) in Q2 2022, closing a stake of 54,649 shares — an estimated $4K sold.

Integrity Capital Management (HK) first reported a position in COEPW in Q4 2021 and held it in 2 quarters. The position peaked at $18K in Q4 2021. 27 funds tracked by Wall St. Rank hold COEPW as of Q2 2022.

  • Integrity Capital Management (HK) reported no remaining Coeptis Therapeutics Warrants position as of Q2 2022 after selling out during the quarter.
  • Integrity Capital Management (HK) sold 54,649 Coeptis Therapeutics Warrants shares in Q2 2022, an estimated $4K.
  • Integrity Capital Management (HK) first reported a position in Coeptis Therapeutics Warrants in Q4 2021 and held it in 2 quarters.
  • Integrity Capital Management (HK)'s Coeptis Therapeutics Warrants position peaked at $18K in Q4 2021.
  • 27 funds tracked by Wall St. Rank held Coeptis Therapeutics Warrants as of Q2 2022.

Based on Integrity Capital Management (HK)'s 13F filing for Q2 2022, filed 28 Jul 2022.